Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Investor Relations

ACET Message Board | Adicet Bio Inc.

home / stock / acet / acet message board

ACET ACET Quote ACET Short ACET News ACET Articles ACET Message Board
New Post

Message Board | Adicet Bio Inc. (NASDAQ:ACET)

Subject By Source When
AviseAnalytics: 7 REASONS TO PUT ADICET BIO ON YOUR WATCHLIST! $ACET Adicet Bio (NASDAQ: ACET) i AviseAnalytics investorshangout 01/24/2022 12:25:33 PM
No sell off...guess I bet wrong masterofdisaster investorshub 12/08/2021 7:41:01 PM
Phase 1's usually suck wind, I lost $80K TheFinalCD investorshub 12/08/2021 2:58:31 PM
It was weird....I think the MMs drop this masterofdisaster investorshub 12/08/2021 12:07:16 PM
whats weird is the rally after the offering TheFinalCD investorshub 12/08/2021 4:10:48 AM
Bought puts today anticipating an offering and there masterofdisaster investorshub 12/07/2021 10:09:39 PM
13.20 low start TheFinalCD investorshub 12/07/2021 9:40:20 AM
14.20 in AH. Nice day for the clinical crudeoil24 investorshub 12/07/2021 1:04:22 AM
thanks for creating the board TheFinalCD investorshub 12/07/2021 12:12:11 AM
Adicet Bio shares are trading higher after the crudeoil24 investorshub 12/06/2021 11:04:36 PM
Adicet Bio Inc. is a biotechnology company that crudeoil24 investorshub 12/06/2021 11:03:47 PM
znewcar1: ACET 38% v48,2M c13.57 f31,9M H15.67 S12.7 znewcar1 investorshangout 12/06/2021 9:22:41 PM
Stock Information
Get ACET Alerts

News, Short Squeeze, Breakout and More Instantly...

Adicet Bio Inc. Company Name:

ACET Stock Symbol:

NASDAQ Market:

2.56% G/L:

$0.7954 Last:

125,374 Volume:

$0.7575 Open:

$0.7954 Close:

Adicet Bio Inc. Website:

Adicet Bio Inc. Logo

Ad

Investor Relations
RECENT ACET NEWS
  • ACET - Adicet Announces Poster Presentations Highlighting ADI-270 Data at the Society for Immunotherapy of Cancer (SITC) 2025 Spring Scientific Meeting

    Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the acceptance of two abstracts for poster presentations at the upcoming Society for Immunotherapy of Canc...

  • ACET - FDA Grants Adicet Bio's ADI-001 Fast Track Designation for SLE Treatment

    2025-02-05 08:44:04 ET DENVER, Colo., Feb 05, 2025 ( 247marketnews.com )- Adicet Bio (NASDAQ: ACET ) stated that the U.S. Food and Drug Administration (FDA) granted Fast Track Designation to ADI-001 for the potential treatment of adult patients with refractory systemic lupus erythem...

  • ACET - Adicet Bio to Participate in a Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference

    Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the Guggenh...

  •
  • Research
  • Stock Search
  • News Releases
  • Articles
  • Topics
  • Message Boards
  • Trending Stocks
  • Trending Feed
  • Trending Alerts
  • Watchlist
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your X Account

Link your X Account to Market Wire News

When you linking your X Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your X account.

Be alerted of any news about your stocks and see what other stocks are trending.

Trending Stock Alerts

Trending Stock Alerts

Our Next Stock Alert could be Coming in Minutes!

Sign Up Today To Get Full Access To Our Next Stock Report!

  • Day Before Email and Text Notifications of New Alerts
  • Day of Email and Text Notifications
  • Trending Stocks, Watchlist and News Releases
  • Mobile App Notifications
Trending Stock Alerts

Get ACET Alerts

Get ACET Alerts

News, Short Squeeze, Breakout and More Instantly...

Sign up or login to continue

Sign up or login to continue.

Forgot password?


Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.

Disclaimer

This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a any stock financial position. any stock's financial position and all other information regarding the featured Company should be verified directly with any stock. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in any company is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of any stock's shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Please read our full disclaimer for compensation and more detailed information.

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

| X

| Facebook

| BlueSky

| LinkedIn

| Telegram

| Discord

Contact

Privacy

Terms of Service

Disclaimer

© 2025 Market Wire News 1